Company intelligence / Profile preview

Proderma Cosmeceutici

Ownership: Private
Development stage: Other

Overview

Proderma is an Italian pharmaceutical company specializing in the research, development, and commercialization of advanced cosmeceutical and dermatological products. The company focuses on creating high-quality topical solutions for various skin conditions, including dermatitis, psoriasis, and photoaging, as well as specialized trichological treatments. Proderma's portfolio is characterized by the use of innovative active ingredients and patented formulations designed to restore skin barrier function and provide therapeutic benefits. Their products are primarily distributed through pharmacies and recommended by dermatologists and pediatricians.

Therapeutic areas: Dermatology
Modalities: Small moleculeTopical formulation
Industry: Biotech

Beyond the preview

Go deeper on Proderma Cosmeceutici.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proderma Cosmeceutici.